Oncology Institute (TOI) Other Non-Current Liabilities (2021 - 2026)

Oncology Institute (TOI) has 6 years of Other Non-Current Liabilities data on file, last reported at $19000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities fell 83.76% year-over-year to $19000.0; the trailing twelve-month figure through Mar 2026 stood at $19000.0 (down 83.76% YoY), and the FY2025 full-year result was $28000.0, down 92.73% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $19000.0, down from $28000.0 in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $13.7 million in Q3 2025 and bottomed at $19000.0 in Q1 2026.
• The 5-year median for Other Non-Current Liabilities is $514000.0 (2024), against an average of $2.9 million.
• The widest annual swing landed in 2023, when Other Non-Current Liabilities plunged 96.37%; it then soared 2557.2% in 2025.
• A 5-year view of Other Non-Current Liabilities shows it stood at $4.0 million in 2022, then tumbled by 90.78% to $365000.0 in 2023, then grew by 5.48% to $385000.0 in 2024, then tumbled by 92.73% to $28000.0 in 2025, then tumbled by 32.14% to $19000.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $19000.0 (Q1 2026), $28000.0 (Q4 2025), and $13.7 million (Q3 2025), per Business Quant data.

Peer Comparison